Inventor · disambiguated record
Tawfik Gharbaoui
Also filed as: GHARBAOUI TAWFIK
22 granted patents·12 pending applications·144 citations·filing 1998–2025
95Inventor score
Files withARENA PHARM INC16MIRATI THERAPEUTICS INC5GHARBAOUI TAWFIK3UNIV FLORIDA STATE3SEMPLE GRAEME2
Top patents by PatentIndex Score
34 records- 0197US9556149B2Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptorARENA PHARM INC·Filed 2014·Granted Jan 31, 2017·16 cites·21 claims
- 0295US11149292B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2016·Granted Oct 19, 2021·8 cites·21 claims
- 0393US9447041B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2015·Granted Sep 20, 2016·12 cites·22 claims
- 0492US9175320B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2014·Granted Nov 3, 2015·15 cites·42 claims
- 0591US10059691B2Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptorARENA PHARM INC·Filed 2017·Granted Aug 28, 2018·4 cites·3 claims
- 0689US8481535B2Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptorGHARBAOUI TAWFIK·Filed 2007·Granted Jul 9, 2013·18 cites·32 claims
- 0789US8299241B2Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereofGHARBAOUI TAWFIK·Filed 2007·Granted Oct 30, 2012·18 cites·66 claims
- 0888US8853419B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereofMONTALBAN ANTONIO GARRIDO·Filed 2011·Granted Oct 7, 2014·17 cites·24 claims
- 0984US7425630B2Processes for preparing pyrazolo[3,4-d]pyrimidine ethersARENA PHARM INC·Filed 2006·Granted Sep 16, 2008·14 cites·74 claims
- 1082US9085581B2Processes for the preparation of S1P1 receptor modulators and crystalline forms thereofJONES ROBERT M·Filed 2011·Granted Jul 21, 2015·6 cites·30 claims
- 1179US12281113B2Crystalline forms of a KRas G12C inhibitorMIRATI THERAPEUTICS INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 1276US11674163B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2021·Granted Jun 13, 2023·0 cites·15 claims
- 1376US7812159B2Processes for preparing aromatic ethersARENA PHARAMACEUTICALS INC·Filed 2006·Granted Oct 12, 2010·10 cites·43 claims
- 1473US2025282778A1Crystalline forms of a kras g12c inhibitorMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1571US9199940B2Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptorARENA PHARM INC·Filed 2013·Granted Dec 1, 2015·1 cites·25 claims
- 1671US2021101885A1Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptorARENA PHARM INC·Filed 2020·Application pending·0 cites
- 1770US2011021538A1Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptorARENA PHARM INC·Filed 2009·Application pending·0 cites
- 1869US12286431B2Crystalline forms of a KRas G12C inhibitorMIRATI THERAPEUTICS INC·Filed 2021·Granted Apr 29, 2025·0 cites·19 claims
- 1968US10787437B2Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptorARENA PHARM INC·Filed 2018·Granted Sep 29, 2020·0 cites·6 claims
- 2059US6441253B1Method for the synthesis of taxanesUNIV FLORIDA STATE·Filed 2000·Granted Aug 27, 2002·2 cites·8 claims
- 2157US6630609B2Taxane synthesis method and intermediatesUNIV FLORIDA STATE·Filed 2002·Granted Oct 7, 2003·1 cites·5 claims
- 2256US2018186748A1Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulaters of the 5-ht2a serotonin receptorARENA PHARM INC·Filed 2017·Application pending·0 cites
- 2356US2024400558A1Processes and intermediates for synthesis of adagrasibMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2455US2025339436A1Crystalline forms of mrtx1133MIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2554US9783502B2Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptorARENA PHARM INC·Filed 2015·Granted Oct 10, 2017·0 cites·10 claims
- 2654US2007032537A15-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseasesARENA PHARM INC·Filed 2004·Application pending·0 cites
- 2751US8637555B2Tetrazole derivatives and methods of treatment of metabolic-related disorders thereofSEMPLE GRAEME·Filed 2004·Granted Jan 28, 2014·0 cites·2 claims
- 2846US2007072924A1Tetrazole derivatives and methods of treatment of metabolic-related disorders thereofSEMPLE GRAEME·Filed 2006·Application pending·0 cites
- 2945US6111144AMethod for the synthesis of a taxane intermediateUNIV FLORIDA STATE·Filed 1998·Granted Aug 29, 2000·2 cites·8 claims
- 3043US2002019013A1Combined resin method for high-speed synthesis of combinatorial librariesFiled 2001·Application pending·0 cites
- 3142US8822727B2Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepineCARLOS MARLON V·Filed 2009·Granted Sep 2, 2014·0 cites·29 claims
- 3241US2006167270A15-substituted 2h-pyrazone-3-carbixylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemiaARENA PHARM INC·Filed 2003·Application pending·0 cites
- 3341US2015284399A1Processes for the preparation of s1p1 receptor modulators and crystalline forms thereofARENA PHARM INC·Filed 2015·Application pending·0 cites
- 3439US2008194836A1Process for Preparing Substituted Phenylpyrazole UreasGHARBAOUI TAWFIK·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tawfik Gharbaoui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →